Table 3 Classification results (Stage II, T factor: T3/T4a)
Optimal combination of markers | Â | ||||
CD4 | FOXP3 | Â | Decision | Sensitivity | Specificity |
High | High | Â | Non-recurrence | 0 (0/3) | 1 (29/29) |
High | Low | Â | Non-recurrence | 0 (0/5) | 1 (28/28) |
Low | High | Â | Non-recurrence | 0 (0/3) | 1 (14/14) |
Low | Low | Â | Recurrence | 1 (23/23) | 0 (0/32) |
| Â | Total | 0.68 (23/34) | 0.69 (71/103) | ||
CD4 | FOXP3 | Histologic grade | Â | ||
High | High | Well/Moderate | Non-recurrence | 0 (0/3) | 1 (28/28) |
High | Highb | Other | Recurrence | Â | 0 (0/1) |
High | Low | Well/Moderate | Non-recurrence | 0 (0/4) | 1 (27/27) |
High | Low | Other | Recurrence | 1 (1/1) | 0 (0/1) |
Low | High | Well/Moderate | Non-recurrence | 0 (0/3) | 1 (14/14) |
Low | High | Other | Â | Â | Â |
Low | Low | Well/Moderate | Recurrence | 1 (21/21) | 0 (0/29) |
Low | Low | Other | Recurrence | 1 (2/2) | 0 (0/3) |
| Â | Total | 0.71 (24/34) | 0.67 (69/103) | ||